Key Takeaways
- • The University of Toronto, McMaster University, Venture Ontario and Genesys Capital have launched the Genesys University Seed Fund, an early-stage life sciences venture capital fund, announced July 8, 2026.
- • The fund has held a first close representing over $30 million in commitments and is accepting additional investment to grow it to up to $40 million.
- • Backers to date include U of T, McMaster, the Temerty Group, Venture Ontario and RBC; U of T and McMaster will act as limited partners and direct fund returns back into research.
- • Genesys Capital, which has invested over $400 million over 25 years and recorded 20 exits, will oversee and manage the fund.
- • The fund targets a funding gap that pushes Ontario life sciences startups toward Boston and Silicon Valley, in a sector with nearly 76,000 workers across more than 2,000 firms.
Summary
The University of Toronto (U of T) and McMaster University, together with Venture Ontario and Genesys Capital, have announced the Genesys University Seed Fund, a new early-stage life sciences venture capital vehicle. According to the announcement, the fund has received support from U of T, McMaster, the Temerty Group, Venture Ontario and RBC, and has held a first close representing over $30 million of commitments. It is currently accepting further investment from private and public sector investors to increase its size to up to $40 million.
The fund is designed to address what the announcement describes as a critical gap in Ontario's life sciences ecosystem. Ontario has nearly 76,000 skilled workers in more than 2,000 firms, one of the largest life sciences clusters in North America, but it trails jurisdictions such as the United States in access to early-stage capital. As a result, many promising Canadian innovators relocate to Boston and Silicon Valley. The partners cite comparable university-linked models at MIT, the University of Pennsylvania, the University of California, Berkeley and Harvard University.
Genesys Capital will manage the fund. The firm reports more than $400 million invested over the past 25 years and 20 exits as a founding investor. U of T President Melanie A. Woodin said Canada "has no shortage of ideas or talent; what we lack is the capital to scale them." McMaster President Susan Tighe cited the university's early success with the McMaster Seed Fund as a foundation for the partnership. Kelly Holman, co-founder and managing director of Genesys Capital, said the firm has supported health startups from both universities.
U of T reports over the past five years it has created more than 1,500 venture-backed startups that have raised over $14 billion and created more than 20,000 jobs, with its Health Innovation Hub including more than 340 active ventures. McMaster reports having supported nearly 400 startups, including Fusion Pharmaceuticals, which AstraZeneca acquired in 2024 for $2 billion USD. Ontario government officials, including Minister of Economic Development Vic Fedeli and Minister of Colleges, Universities, Research Excellence and Security Nolan Quinn, and Venture Ontario President and CEO Steve Romanyshyn, also issued supporting statements. Limited partners U of T and McMaster will direct fund returns to further research. Investor inquiries are directed to [email protected].
The fund is designed to address what the announcement describes as a critical gap in Ontario's life sciences ecosystem. Ontario has nearly 76,000 skilled workers in more than 2,000 firms, one of the largest life sciences clusters in North America, but it trails jurisdictions such as the United States in access to early-stage capital. As a result, many promising Canadian innovators relocate to Boston and Silicon Valley. The partners cite comparable university-linked models at MIT, the University of Pennsylvania, the University of California, Berkeley and Harvard University.
Genesys Capital will manage the fund. The firm reports more than $400 million invested over the past 25 years and 20 exits as a founding investor. U of T President Melanie A. Woodin said Canada "has no shortage of ideas or talent; what we lack is the capital to scale them." McMaster President Susan Tighe cited the university's early success with the McMaster Seed Fund as a foundation for the partnership. Kelly Holman, co-founder and managing director of Genesys Capital, said the firm has supported health startups from both universities.
U of T reports over the past five years it has created more than 1,500 venture-backed startups that have raised over $14 billion and created more than 20,000 jobs, with its Health Innovation Hub including more than 340 active ventures. McMaster reports having supported nearly 400 startups, including Fusion Pharmaceuticals, which AstraZeneca acquired in 2024 for $2 billion USD. Ontario government officials, including Minister of Economic Development Vic Fedeli and Minister of Colleges, Universities, Research Excellence and Security Nolan Quinn, and Venture Ontario President and CEO Steve Romanyshyn, also issued supporting statements. Limited partners U of T and McMaster will direct fund returns to further research. Investor inquiries are directed to [email protected].
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.